Intentional self-harm by jumping or lying before moving object

VWXY20_INTENTI_SELF_H_JUMPI_LYING_MOVING_OBJECT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X81 Cause of death: ICD-10 — X81 2 out of 7 registries used, show all original rules.	57
4. Check minimum number of events None	57
5. Include endpoints None	57
6. Filter based on genotype QC (FinnGen only)	57

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X[6-7]|X8[0-4]

NAME	VWXY20_INTENTI_SELF_H_JUMPI_LYING_MOVING_OBJECT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X81
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X81
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Intentional self-harm by jumping or lying before moving object based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	57	24	33
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	36.53	37.11	36.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55: Matched controls
549

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X81

ICD-10 Finland

Intentional self-harm by jumping or lying before moving object

+∞

78.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

39.1

25.4

N05AH04

ATC

quetiapine; oral

21.6

22.0

N05AH03

ATC

olanzapine; systemic

28.6

20.1

N05AX12

ATC

aripiprazole; systemic

21.5

12.4

N05AX08

ATC

risperidone; systemic

14.0

11.9

F29

ICD-10 Finland

Unspecified nonorganic psychosis

18.2

9.9

N03AG01

ATC

valproic acid; systemic, rectal

12.4

9.4

N05AH02

ATC

clozapine; systemic

30.0

9.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

14.2

9.0

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

25.0

8.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

15.1

8.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

15.1

8.7

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

8.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.3

8.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.7

8.1

N05CF01

ATC

zopiclone; oral

5.8

8.0

F99

ICD-10 Finland

Mental disorder, not otherwise specified

22.4

8.0

N05BA06

ATC

lorazepam; systemic, sublingual

16.6

7.8

N05BA04

ATC

oxazepam; oral

6.5

7.7

N06AB04

ATC

citalopram; systemic

6.1

7.2

N06AB06

ATC

sertraline; oral

7.1

N05AA02

ATC

levomepromazine; systemic

14.9

6.9

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

78.6

6.6

F20.9

ICD-10 Finland

Schizophrenia, unspecified

30.6

6.4

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

17.5

6.1

N05BA01

ATC

diazepam; systemic, rectal

6.9

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

10.93

10.67

3.6

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

396

0.20

7.70

3.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

6.18

6.59

4.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

5.44

5.02

4.6

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

13.01

4.95

35.9

11.4

1100.25

1230.14

nmol/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

13.01

4.95

24.4

9.0

643.75

787.14

nmol/l

—

(3016879) Cocaine [Presence] in Urine

4.52

4.67

3.6

1.2

—

(3028300) Cannabinoids [Presence] in Urine

4.02

4.04

3.7

1.2

—

(3027008) Opiates [Presence] in Urine

4.02

4.04

3.6

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

3.91

3.90

3.6

1.2

—

(3027944) Amphetamines [Presence] in Urine

3.91

3.90

3.6

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

463

0.34

3.60

21.9

10.5

40.77

41.72

0.35

408

(3012544) pH of Venous blood

4.28

3.53

2.9

4.1

—

(40758558) Short blood count panel - Blood

2.56

2.59

13.9

5.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

444

0.42

2.46

4.9

3.7

2.81

2.83

mmol/l

0.05

422

(1761868) Lipid panel - Serum or Plasma

214

0.35

2.37

2.9

2.4

—

(42870588) Differential panel, method unspecified - Blood

113

2.36

2.32

7.5

6.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

2.21

0.0

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3.84

2.13

15.1

12.8

8.90

7.14

mmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

437

0.45

2.12

4.5

3.5

1.39

mmol/l

0.01

414

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.14

2.11

2.9

2.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4.86

1.98

2.2

13.6

23.20

24.45

mmol/l

—

(3002256) Pathology report gross observation

0.00

1.60

0.0

1.2

—

(40768804) Tissue Pathology biopsy report

157

0.43

1.57

1.9

1.6

—

(3000991) Gas panel - Venous blood

2.92

1.47

2.3

8.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.32

1.47

3.8

1.1

—

(3000492) Spirometry study

0.00

1.39

0.0

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.94

1.31

3.0

3.6

22.48

24.41

mmol/l

—

(3023368) Bacteria identified in Blood by Culture

2.01

1.23

3.2

5.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

122

1.84

1.23

2.0

1.6

86.95

95.50

pmol/l

0.37

(40761511) CBC panel - Blood by Automated count

481

0.52

1.23

20.7

9.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.95

1.14

1.6

1.7

—

(40761535) Cells panel - Urine sediment

2.51

1.11

3.6

3.0

—

(3026008) Bacteria identified in Urine by Culture

1.88

1.10

1.9

2.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

1.00

0.0

1.5

—

(3008898) HLA-B27 [Presence]

0.00

0.98

0.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1.89

0.94

1.7

367.83

520.30

pmol/l

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.95

0.90

1.1

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.95

0.90

1.4

1.8

—

(3013512) EKG study

1.76

0.87

4.2

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.81

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.81

0.0

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.79

0.0

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.69

0.76

1.6

1.9

—

(3003694) ABO and Rh group [Type] in Blood

127

0.57

0.75

1.6

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.09

0.74

2.0

1.5

0.00

0.02

e6/l

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2.01

0.72

3.0

3.1

251.80

227.54

u/l

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

375

0.67

0.72

5.9

4.5

37.09

38.77

mmol/mol

0.56

364

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.86

0.68

7.0

3.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

170

0.63

0.67

3.9

4.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

124

0.59

0.63

1.9

1.8

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.61

0.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.61

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.61

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.59

0.0

1.3

—

(4035726)

0.00

0.59

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.59

0.0

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.59

0.0

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.59

0.0

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.59

0.0

1.3

—

(3044889) 12 lead EKG panel

255

1.37

0.50

4.4

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1.54

0.48

1.7

1.4

21.17

20.49

nmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

454

0.72

0.42

19.0

10.3

21.28

21.08

mg/l

0.02

342

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.42

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.42

0.0

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.42

0.0

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.41

0.0

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.40

0.0

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.63

0.39

1.4

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

283

0.79

0.31

3.4

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

143

1.27

0.27

2.1

—

(3032080) INR in Blood by Coagulation assay

115

1.29

0.27

7.9

8.0

1.08

1.12

inr

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.69

0.26

1.5

1.9

—

(40761536) Microorganisms panel - Urine sediment

1.31

0.23

2.4

2.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.27

0.23

2.6

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

1.50

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.21

0.0

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

0.30

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

3.5

—

207.70

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

472.80

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.21

0.0

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

21.83

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

49.62

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

2.1

—

88.62

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.25

0.21

1.7

1.6

—

(3015736) pH of Urine

150

1.19

0.17

2.4

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.17

0.16

3.0

2.2

—

(3030467) Casts [#/volume] in Urine by Automated count

106

0.82

0.14

1.3

2.1

0.35

e6/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.18

0.11

1.9

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

106

1.17

0.11

2.5

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

126

1.15

0.10

2.9

2.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.10

0.09

1.3

2.1

3.00

2.75

e6/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.04

0.09

4.5

2.3

10.90

15.47

nmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

0.81

0.08

1.2

3.0

—

(3026782) Osmolality of Urine

1.09

0.08

1.5

1.9

479.00

541.52

mosm/kgh2o

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1.15

0.07

1.5

1.6

1.82

0.65

mg/l

—

(3033658) Prothrombin time (PT) actual/Normal

0.88

0.07

8.8

3.7

73.00

96.81

—

(3002582) Erythrocytes [#/volume] in Urine

120

1.11

0.05

1.7

2.1

32.94

29.42

e6/l

0.06

(3041096) Erythrocytes [Presence] in Urine by Automated

130

0.90

0.05

2.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

159

0.92

0.04

2.4

2.8

—

(36304419) Bacteria [Presence] in Urine

107

0.92

0.02

1.3

2.0

—

(3018095) Leukocytes [#/volume] in Urine

136

0.94

0.01

2.1

2.7

16.59

20.99

e6/l

0.16

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

105

1.06

0.00

2.1

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

116

1.04

0.00

14.2

5.1

—

(3044640) Blood type and Crossmatch panel - Blood

106

1.05

0.00

3.1

2.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.3

—

4.97

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

0.91

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

147.68

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.0

3.3

—

0.30

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

2.0

—

5.73

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

4.5

—

1.37

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

262.60

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

5.16

—

(4306422)

0.00

0.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.0

—

24.11

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

1.4

—

109.60

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

49.20

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

1.9

—

1.21

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.4

—

13.00

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.6

—

(4027681)

0.00

0.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

3.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

0.00

0.0

1.7

—

0.46

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

121.20

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.3

—

(3042936) Bacteria identified in Isolate by Culture

0.94

0.00

3.8

2.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.4

—

18.60

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.0

3.0

—

21.50

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

12.26

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

3.80

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

3.2

—

97.80

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.44

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.7

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

1.4

—

3.96

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_INTENTI_SELF_H_JUMPI_LYING_MOVING_OBJECT – Intentional self-harm by jumping or lying before moving object

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Intentional self-harm by jumping or lying before moving object

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Intentional self-harm by jumping or lying before moving object (VWXY20_INTENTI_SELF_H_JUMPI_LYING_MOVING_OBJECT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints